短期机械循环支持后过渡至恢复患者的中期结局
本研究回顾性分析了2010至2016年间502例接受短期机械循环支持的心源性休克患者,其中149例(29.7%)成功脱离设备并存活出院,纳入分析。中位随访306天,主要终点为无心脏替代治疗的中期生存,3年无事件生存率为74.2%,急性心肌梗死患者预后显著较差(40.4%)。
要点
- 短期机械循环支持后过渡至恢复的患者中期结局总体良好,3年无事件生存率74.2%。
- 急性心肌梗死病因患者无事件生存率仅40.4%,显著低于其他病因。
- 单因素分析显示AMI病因、支持时长、出院时BUN和LVEF与不良事件相关。
核心结论
- 短期机械循环支持后成功脱机的患者中期结局总体良好,但急性心肌梗死患者预后显著较差。
研究设计与样本
- 回顾性队列研究,纳入2010至2016年502例接受静脉-动脉体外膜氧合或临时外科心室辅助装置的心源性休克患者,其中149例(29.7%)存活出院并纳入分析。
主要发现
- 中位随访306天(IQR 58.25-916.75天)期间,24例(16.1%)发生主要事件,包括21例死亡和3例接受心脏替代治疗。
- 总体3年无事件生存率为74.2%。
- 急性心肌梗死患者3年无事件生存率显著更低,为40.4%(p < 0.001)。
- 单因素Cox分析显示,急性心肌梗死病因(p = 0.003)、短期机械循环支持时长(p = 0.06)、出院时血尿素氮(p = 0.012)和左心室射血分数(p = 0.005)是不良事件的预测因素。
临床怎么用
- 对于短期机械循环支持后过渡至恢复的患者,应关注急性心肌梗死病因、支持时长及出院时BUN和LVEF,以识别中期不良事件高风险者。
局限性
- 回顾性研究设计,样本来自单中心,可能存在选择偏倚;仅纳入存活出院患者,未涵盖所有过渡至恢复患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The use of short-term mechanical circulatory support (ST-MCS) has increased for refractory cardiogenic shock. However, there are scant data about bridge-to-recovery patients. METHODS: We retrospectively reviewed 502 patients with cardiogenic shock who received venoarterial extracorporeal membrane oxygenation or a temporary surgical ventricular assist device as ST-MCS between 2010 and 2016. There were 178 patients (35.5%) who survived through device explantation. Of these, 149 patients (29.7%) survived to discharge and were included for analysis. The primary outcome was midterm survival without undergoing heart replacement therapy. RESULTS: In our bridge-to-recovery cohort, 101 patients (67.8%) were men, and the median age was 59 years (interquartile range, 51 to 67 years). Etiology of cardiogenic shock included postcardiotomy shock in 35.6% of patients (n = 53), allograft failure in 26.8% (n = 40), acute myocardial infarction (AMI) in 24.2% (n = 36), and other acute decompensated heart failure in 14.4% (n = 20). There were 24 major events (16.1%) recorded, including 21 patients who died and 3 patients who received heart replacement therapy during median follow-up of 306 days (interquartile range, 58.25 to 916.75 days). Overall freedom from event at 3 years was 74.2%. In subgroup analysis, AMI patients had a significantly worse freedom-from-event rate at 40.4% (p < 0.001). By univariate Cox analysis, AMI etiology (p = 0.003), length of ST-MCS (p = 0.06), blood urea nitrogen (p = 0.012), and left ventricular ejection fraction (p = 0.005) at discharge were predictors for adverse events. CONCLUSIONS: The overall midterm outcome of patients explanted from ST-MCS is favorable except for AMI patients.
引用
- Cheng YT, Garan AR, Sanchez J, et al. Midterm Outcomes of Bridge-to-Recovery Patients After Short-Term Mechanical Circulatory Support. Ann Thorac Surg. 2019. PMID: 30851259. doi:10.1016/j.athoracsur.2019.01.060
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。